title: Subcutaneous lipoatrophy induced by long-term pegvisomant administration.
authors.forename: Cannavo
authors.initials: C
authors.lastname: Salvatore
authors.forename: Romanello
authors.initials: R
authors.lastname: Giovanni
authors.forename: Cavallari
authors.initials: C
authors.lastname: Vittorio
authors.forename: Scisca
authors.initials: S
authors.lastname: Claudio
authors.forename: Cannavo Serafinella
authors.initials: CS
authors.lastname: Patrizia
mesh_terms: D000172:Acromegaly / Q000188:drug therapy; D000328:Adult; D001284:Atrophy / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D019382:Human Growth Hormone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D050151:Subcutaneous Fat / Q000473:pathology*
chemical_list: D019382:Human Growth Hormone; C406545:pegvisomant